|
TCTE3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.152000E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.640100E-02 |
| Normal-vs-Stage2 |
4.852600E-01 |
| Normal-vs-Stage3 |
2.858100E-03 |
| Normal-vs-Stage4 |
2.155000E-01 |
| Stage1-vs-Stage2 |
1.964430E-01 |
| Stage1-vs-Stage3 |
1.168640E-01 |
| Stage1-vs-Stage4 |
8.891600E-01 |
| Stage2-vs-Stage3 |
9.401500E-02 |
| Stage2-vs-Stage4 |
2.116200E-01 |
| Stage3-vs-Stage4 |
5.120600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.064200E-03 |
| Normal-vs-AfricanAmerican |
2.064400E-02 |
| Normal-vs-Asian |
7.466000E-01 |
| Caucasian-vs-AfricanAmerican |
7.267600E-01 |
| Caucasian-vs-Asian |
2.620300E-02 |
| AfricanAmerican-vs-Asian |
7.867800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.411850E-01 |
| Normal-vs-Female |
7.393900E-02 |
| Male-vs-Female |
8.958400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.196400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.622220E-01 |
| Normal-vs-Age(61-80Yrs) |
7.004600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.006000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.835400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.905400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.923200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.162800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.498820E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.490300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.086360E-02 |
| Classical-VS-Follicular |
5.252400E-02 |
| Classical-VS-Other |
3.082200E-01 |
| Classical-VS-Normal |
2.967700E-02 |
| Tall-VS-Follicular |
3.599400E-03 |
| Tall-VS-Other |
1.833800E-02 |
| Tall-VS-Normal |
3.030800E-04 |
| Follicular-VS-Other |
6.377200E-01 |
| Follicular-VS-Normal |
4.114400E-01 |
| Other-VS-Normal |
8.903600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.040400E-01 |
| Normal-vs-N1 |
7.442400E-01 |
| N0-vs-N1 |
6.352400E-01 |
|
|
